By Taren Grom
Real-world evidence, important for regulatory decision-making, is beginning to touch all areas of the healthcare value chain.
November 20, 2020
Why sign up? Because transforming drug development is not just our goal—it’s our obsession. If it’s yours too, then be the first to know of new insights and join us in pushing the boundaries of science.
